Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Chronic Heart Failure

Free Subscription Articles published in Int J Cardiol Retrieve available abstracts of 354 articles: HTML format

Single Articles

February 2026
1. GUIDA G, Castelvecchio S, Disabato G, Attanasio A, et al
   Long-term outcomes of surgical ventricular reconstruction: Insight from cardiac magnetic resonance.
   Int J Cardiol. 2026;445:134051.
   PubMed     Abstract available
   
   
   
2. ZHANG Q, Li W, Wang S, Zhang H, et al
   Stress echocardiography based RV-pulmonary coupling predicts rehospitalization and mortality in HFpEF.
   Int J Cardiol. 2026;445:134034.
   PubMed     Abstract available
   
   
   December 2025
3. WANG L, Zhou J, Zhao L
   Surgical ventricular reconstruction in ischemic heart failure: The evolving role of cardiac magnetic resonance.
   Int J Cardiol. 2025 Dec 15:134089. doi: 10.1016/j.ijcard.2025.134089.
   PubMed    
   
   
   
4. BAUMBERGER J, Meyer P, Kohler M, Huber LC, et al
   Inter-specialty differences and knowledge gaps in acute and advanced heart failure care.
   Int J Cardiol. 2025;446:134091.
   PubMed     Abstract available
   
   
   
5. DUDDA J, Behnes M, Weidner K, Lau F, et al
   Platelet counts and prognosis in heart failure with mildly reduced ejection fraction: Results from a large-scaled registry.
   Int J Cardiol. 2025 Dec 9:134088. doi: 10.1016/j.ijcard.2025.134088.
   PubMed     Abstract available
   
   
   
6. OZAKI Y, Uemura Y, Kondo T, Kazama S, et al
   Pulmonary artery Pulsatility index and compliance for hemodynamic risk classification in heart failure.
   Int J Cardiol. 2025;445:134079.
   PubMed     Abstract available
   
   
   
7. ATIF MM, Lohano G, Ram M, Irshad NUN, et al
   Letter to the editor: Outcomes in patients undergoing trans-catheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
   Int J Cardiol. 2025;440:133699.
   PubMed    
   
   
   
8. PANG X, Zhao S, Zhang F
   Comment on: "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population".
   Int J Cardiol. 2025;440:133698.
   PubMed    
   
   
   
9. SCHUKRAFT S, Muller M, Abdurashidova T, Soborun N, et al
   Female sex and survival in patients hospitalized with acute heart failure and renal dysfunction.
   Int J Cardiol. 2025 Dec 1:134019. doi: 10.1016/j.ijcard.2025.134019.
   PubMed     Abstract available
   
   
   November 2025
10. TAKAHAMA H, Nochioka K, Miyata S, Hayashi H, et al
    Association of Body Mass Index with ten-year outcomes in asymptomatic stage a/B heart failure patients: Insights from the CHART-2 study.
    Int J Cardiol. 2025 Nov 26:134062. doi: 10.1016/j.ijcard.2025.134062.
    PubMed     Abstract available
    
    
    
11. CHEN X, Zhang X, Yang M, Shan C, et al
    The influence of non-cardiac comorbidities burden on heart failure with improved ejection fraction: Evaluated by Charlson comorbidity index.
    Int J Cardiol. 2025 Nov 26:134063. doi: 10.1016/j.ijcard.2025.134063.
    PubMed     Abstract available
    
    
    
12. PELLICORI P, Rastogi T, Palazzuoli A, Ruocco G, et al
    Systemic and pulmonary congestion by ultrasound and prognosis in heart failure: A pooled cohort analysis.
    Int J Cardiol. 2025;445:134033.
    PubMed     Abstract available
    
    
    
13. ASTENGO M, Lindow T, Bobbio E, Bollano E, et al
    Echocardiographic grading of right ventricular dysfunction improves risk stratification of patients with severe heart failure.
    Int J Cardiol. 2025 Nov 17:134026. doi: 10.1016/j.ijcard.2025.134026.
    PubMed     Abstract available
    
    
    
14. TAKAGI R, Kobayashi M, Kuwahara A, Takihara K, et al
    Trajectory, correlates, and outcomes of pulmonary congestion by lung ultrasound in patients hospitalized for acute pulmonary edema.
    Int J Cardiol. 2025;438:133599.
    PubMed     Abstract available
    
    
    
15. ZAMORANO JL, Voros G, Calvi V, Osca J, et al
    Sex-specific response to cardiac resynchronization therapy: the BIO|WOMEN trial.
    Int J Cardiol. 2025;438:133526.
    PubMed     Abstract available
    
    
    
16. LANG Z, Girerd N, Zhang H, Xu H, et al
    Validation of a noninvasive device for measuring filling pressure against invasive pulmonary capillary wedge pressure.
    Int J Cardiol. 2025;438:133479.
    PubMed     Abstract available
    
    
    October 2025
17. SHIRAKABE A, Ikeda Y, Uchikado Y, Okazaki H, et al
    Clinical significance of mitochondrial dynamics-related miRNAs in the superacute phase of acute heart failure in patients presenting to the emergency department.
    Int J Cardiol. 2025;444:133967.
    PubMed     Abstract available
    
    
    
18. YAFASOVA A, Doi SN, Thune JJ, Nielsen JC, et al
    Effect of implantable cardioverter-defibrillator in non-ischemic heart failure according to heart failure etiology: Extended follow-up of the DANISH trial.
    Int J Cardiol. 2025;443:133969.
    PubMed     Abstract available
    
    
    
19. YANG L, Chen X, Fang Y, Chen D, et al
    Rate-adaptive pacing in right-sided heart failure with tricuspid regurgitation: A prospective pilot study.
    Int J Cardiol. 2025 Oct 6:133957. doi: 10.1016/j.ijcard.2025.133957.
    PubMed     Abstract available
    
    
    September 2025
20. OKUMURA T, Hiraiwa H, Yanagisawa S, Takefuji M, et al
    Plasma proteomics and heart failure: A new frontier beyond ejection fraction.
    Int J Cardiol. 2025 Sep 30:133943. doi: 10.1016/j.ijcard.2025.133943.
    PubMed    
    
    
    
21. KASSAB VP, Oldra LGO, Milanesi GS, de Souza FR, et al
    Reply to "critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy".
    Int J Cardiol. 2025 Sep 26:133911. doi: 10.1016/j.ijcard.2025.133911.
    PubMed    
    
    
    
22. VAN ESSEN BJ, Dan NAE, Tharsana GN, Kaur P, et al
    Obesity and inactivity cluster the strongest risk factor for the development of heart failure in a population-based study.
    Int J Cardiol. 2025 Sep 19:133914. doi: 10.1016/j.ijcard.2025.133914.
    PubMed     Abstract available
    
    
    
23. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Reply to "Reconsidering thyroid hormone assessment in heart failure risk prediction".
    Int J Cardiol. 2025 Sep 16:133912. doi: 10.1016/j.ijcard.2025.133912.
    PubMed    
    
    
    
24. ALAWAJNEH MM, Aljabali A, Theeb L, Tashtoush S, et al
    Predictors of discontinuation and non-publication of heart failure clinical trials: A cross-sectional analysis of ClinicalTrials.gov data.
    Int J Cardiol. 2025;442:133901.
    PubMed     Abstract available
    
    
    
25. LI L
    Re-evaluating composite CRP-based ratios in chronic heart failure: clarity beyond novelty.
    Int J Cardiol. 2025 Sep 12:133899. doi: 10.1016/j.ijcard.2025.133899.
    PubMed    
    
    
    
26. CHEN X, Zhang Q, Bao Y
    Reconsidering thyroid hormone assessment in heart failure risk prediction.
    Int J Cardiol. 2025 Sep 8:133872. doi: 10.1016/j.ijcard.2025.133872.
    PubMed    
    
    
    
27. UMAR M, Zaheer M, Gillani Z
    Letter to the Editor: Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
    Int J Cardiol. 2025 Sep 6:133871. doi: 10.1016/j.ijcard.2025.133871.
    PubMed    
    
    
    
28. RANA AM, Rafay MA, Amjad MW, Aslam MH, et al
    Critical appraisal of early diagnosis and progression to heart failure with preserved ejection fraction among hypertensive patients with left ventricular hypertrophy.
    Int J Cardiol. 2025 Sep 6:133877. doi: 10.1016/j.ijcard.2025.133877.
    PubMed    
    
    
    
29. ABOU KAMAR S, van Ommen AM, Dal Canto E, Valstar G, et al
    The plasma proteome is linked to echocardiographic parameters and stages of diastolic dysfunction, across the ejection fraction spectrum.
    Int J Cardiol. 2025;434:133329.
    PubMed     Abstract available
    
    
    August 2025
30. NOIRI JI, Tanaka H
    Authors' reply to Zhang et al. regarding "Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 28:133840. doi: 10.1016/j.ijcard.2025.133840.
    PubMed    
    
    
    
31. ZHANG L, Luo Z, Lin R
    Comment on "Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 28:133841. doi: 10.1016/j.ijcard.2025.133841.
    PubMed    
    
    
    
32. MONZO L, Girerd N
    Decoding the inflammatory-metabolic code: machine learning potential for outcome prediction in heart failure with diabetes.
    Int J Cardiol. 2025 Aug 27:133828. doi: 10.1016/j.ijcard.2025.133828.
    PubMed    
    
    
    
33. MEGHWAR S, Bhagwan R, Naqvi SMM, Wali F, et al
    Trends in heart failure-related mortality among psychoactive drug users in the United States: A nationwide cross-sectional analysis of the CDC WONDER database.
    Int J Cardiol. 2025;441:133790.
    PubMed     Abstract available
    
    
    
34. PALM CL, de Wit S, Gorter TM, Rienstra M, et al
    Reply to Letter to the Editor: Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025 Aug 19:133809. doi: 10.1016/j.ijcard.2025.133809.
    PubMed    
    
    
    
35. NOIRI JI, Tanaka H
    Authors' reply to Wang on frailty dynamics and implementation in super aged heart failure.
    Int J Cardiol. 2025 Aug 18:133799. doi: 10.1016/j.ijcard.2025.133799.
    PubMed    
    
    
    
36. REN JM, Wang YG, Zheng JL, Wang WY, et al
    Thyroid hormones were associated with incident heart failure subtypes and changes in cardiac structure and function: results from the atherosclerosis risk in communities study.
    Int J Cardiol. 2025;441:133794.
    PubMed     Abstract available
    
    
    
37. BARACCHINI N, Capovilla TM, Rossi M, Carriere C, et al
    Unveiling the limitations of non-metabolic thresholds in assessing maximal effort: The role of cardiopulmonary exercise testing.
    Int J Cardiol. 2025;433:133292.
    PubMed     Abstract available
    
    
    
38. CARLUCCIO E, Fortuni F, Ambrosio G
    Don't stop now: The imperative to maintain SGLT2 inhibitors in older patients with heart failure.
    Int J Cardiol. 2025;441:133775.
    PubMed    
    
    
    
39. NOIRI JI, Tanaka H
    Authors' reply to Wang et al. regarding "Efficacy of sodium glucose cotransporter 2 inhibitors for super aged heart failure population".
    Int J Cardiol. 2025 Aug 12:133782. doi: 10.1016/j.ijcard.2025.133782.
    PubMed    
    
    
    
40. NOIRI JI, Tanaka H
    Authors' reply to Hong et al. regarding "Efficacy of sodium glucose cotransporter 2 inhibitors for super aged heart failure population".
    Int J Cardiol. 2025 Aug 12:133783. doi: 10.1016/j.ijcard.2025.133783.
    PubMed    
    
    
    
41. WANG Y
    Optimizing SGLT2 inhibitor continuation in super-aged heart failure.
    Int J Cardiol. 2025 Aug 9:133759. doi: 10.1016/j.ijcard.2025.133759.
    PubMed    
    
    
    
42. ZHU Y, Guo J
    Omics-driven strategy develops a tumor biomarker-derived signature to forecast the occurrence and progression of heart failure.
    Int J Cardiol. 2025 Aug 9:133742. doi: 10.1016/j.ijcard.2025.133742.
    PubMed     Abstract available
    
    
    
43. HU Y, Zhang Y, Han P, Pan Y, et al
    Machine learning-driven prediction of readmission risk in heart failure patients with diabetes: synergistic assessment of inflammatory and metabolic biomarkers.
    Int J Cardiol. 2025;441:133743.
    PubMed     Abstract available
    
    
    
44. HONG F, Sun B
    Comment on efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population.
    Int J Cardiol. 2025 Aug 7:133739. doi: 10.1016/j.ijcard.2025.133739.
    PubMed    
    
    
    
45. ZHU B, Xu Y
    Expanding generalizability and addressing bias in mobile app-assisted heart failure screening.
    Int J Cardiol. 2025 Aug 7:133738. doi: 10.1016/j.ijcard.2025.133738.
    PubMed    
    
    
    
46. HASUMI E, Fujiu K
    Reply to "Comments: Heart failure monitoring with a single-lead electrocardiogram at home".
    Int J Cardiol. 2025 Aug 6:133734. doi: 10.1016/j.ijcard.2025.133734.
    PubMed    
    
    
    
47. WANG K, Gao W
    Letter to "efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population".
    Int J Cardiol. 2025 Aug 4:133712. doi: 10.1016/j.ijcard.2025.133712.
    PubMed    
    
    
    
48. WANG B
    Letter to the Editor: Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Aug 4:133701. doi: 10.1016/j.ijcard.2025.133701.
    PubMed    
    
    
    
49. HUANG Z, Pan L, Xiao Z, Rao F, et al
    Kirenol attenuates pressure overload-induced heart failure by enhancing autophagy in macrophages.
    Int J Cardiol. 2025;440:133681.
    PubMed     Abstract available
    
    
    
50. GHANI AI, Rehman A, Kazi ZA
    Letter to the Editor: Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
    Int J Cardiol. 2025 Aug 2:133715. doi: 10.1016/j.ijcard.2025.133715.
    PubMed    
    
    
    
51. KASSAB VP, Oldra LGO, Milanesi GS, Souza FR, et al
    Evaluation of early diagnosis and progression to heart failure with preserved ejection fraction: A retrospective study in patients with arterial hypertension and left ventricular hypertrophy.
    Int J Cardiol. 2025 Aug 1:133672. doi: 10.1016/j.ijcard.2025.133672.
    PubMed     Abstract available
    
    
    
52. AAMIR M, Bilquees A, Saleem D
    Addressing confounding factors in TEER outcomes: A call for deeper analysis [Re: Meulengracht et al., International Journal of Cardiology 439 (2025) 133605 - "Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared t
    Int J Cardiol. 2025 Aug 1:133702. doi: 10.1016/j.ijcard.2025.133702.
    PubMed    
    
    
    July 2025
53. SCHUPP T, Akin I, Behnes M
    Response to Letter by Dong et al.: BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133673.
    PubMed    
    
    
    
54. YADAV A, Yadav O, Gupta N, Gupta R, et al
    Comments: Heart failure monitoring with a single?lead electrocardiogram at home.
    Int J Cardiol. 2025;439:133659.
    PubMed    
    
    
    
55. DONG C, Cui Y, Sima M, Yue D, et al
    Letter regarding the study by Kuhn et al. on BMI and heart failure readmission risk: Rethinking obesity assessment.
    Int J Cardiol. 2025;439:133656.
    PubMed    
    
    
    
56. PAN Z, Liu R, Wang H
    Clarifying the clinical utility of serum DKK1 as a biomarker in PH-related right heart failure.
    Int J Cardiol. 2025 Jul 22:133661. doi: 10.1016/j.ijcard.2025.133661.
    PubMed    
    
    
    
57. STEFANOVIC M, Trifunovic-Zamaklar D, Mladenovic Z, Tadic S, et al
    Utility of Mobile phone app-assisted screening for heart failure in primary care: Insights from the ECHOS3 registry.
    Int J Cardiol. 2025 Jul 22:133651. doi: 10.1016/j.ijcard.2025.133651.
    PubMed     Abstract available
    
    
    
58. ZEB MU, Atta A
    Letter to the editor: Real-world challenges for guideline-directed medical therapy intolerance in heart failure: A single-center prospective cohort study.
    Int J Cardiol. 2025 Jul 21:133652. doi: 10.1016/j.ijcard.2025.133652.
    PubMed    
    
    
    
59. NOIRI JI, Tanaka H, Odajima S, Fujimoto W, et al
    Efficacy of sodium-glucose cotransporter 2 inhibitors for super-aged heart failure population.
    Int J Cardiol. 2025;439:133647.
    PubMed     Abstract available
    
    
    
60. GAO S, Yan Y, Liu L
    Navigating pharmacotherapy in heart failure complicated by atrial fibrillation: A practical summary.
    Int J Cardiol. 2025;439:133640.
    PubMed    
    
    
    
61. VENNER MFGHM, Gevers TJG, Ploum F, Habets J, et al
    Diastolic dysfunction as predictive parameter for the development of post-TIPS cardiac decompensation.
    Int J Cardiol. 2025;431:133226.
    PubMed     Abstract available
    
    
    
62. PAGNESI M, Adamo M
    Reply to letter: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025;439:133611.
    PubMed    
    
    
    
63. MEULENGRACHT DE, Petersen JK, Veien KT, de Backer O, et al
    Outcomes in patients undergoing transcatheter edge-to-edge mitral valve repair as compared to a general and heart failure population.
    Int J Cardiol. 2025 Jul 7:133605. doi: 10.1016/j.ijcard.2025.133605.
    PubMed     Abstract available
    
    
    
64. DUHAN S, Kurpad KP, Keisham B, Shtembari J, et al
    GLP-1RA versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: An updated meta-analysis of randomized controlled trials.
    Int J Cardiol. 2025;438:133604.
    PubMed     Abstract available
    
    
    
65. ESTLER B, Frohlich H, Tager T, Hund H, et al
    Endothelial dysfunction assessed by the endothelial activation and stress index (EASIX) predicts risk of mortality in chronic heart failure patients.
    Int J Cardiol. 2025;438:133566.
    PubMed     Abstract available
    
    
    
66. KAMAR SA, van Ommen AM, Canto ED, van Dalen BM, et al
    Reply to 'unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research'.
    Int J Cardiol. 2025 Jul 1:133576. doi: 10.1016/j.ijcard.2025.133576.
    PubMed    
    
    
    June 2025
67. SONG Y, Ma F, Bao X, Liu Y, et al
    Letter to editor: Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
    Int J Cardiol. 2025 Jun 25:133560. doi: 10.1016/j.ijcard.2025.133560.
    PubMed    
    
    
    
68. PONTIROLI AE, Ambrosio G, Leoni O, Forlani M, et al
    Reply to letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection", by Dr. Mehta and Dr. Sah.
    Int J Cardiol. 2025 Jun 25:133557. doi: 10.1016/j.ijcard.2025.133557.
    PubMed    
    
    
    
69. MANN C, Braunwald E, Zelniker TA
    Diabetic cardiomyopathy revisited: The interplay between diabetes and heart failure.
    Int J Cardiol. 2025 Jun 24:133554. doi: 10.1016/j.ijcard.2025.133554.
    PubMed     Abstract available
    
    
    
70. MERT GO, Spartalis M, Murat S, Gorenek B, et al
    Commentary on ventricular arrhythmias in acute heart failure: Critical insights into the 2024 ESC-EHRA-ACVC-HFA consensus.
    Int J Cardiol. 2025 Jun 24:133544. doi: 10.1016/j.ijcard.2025.133544.
    PubMed     Abstract available
    
    
    
71. LAVA SAG
    SGLT2 inhibitors for paediatric heart failure: time for innovative trials.
    Int J Cardiol. 2025;438:133521.
    PubMed    
    
    
    
72. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Sivadasanpillai H, et al
    Reply to comment on "The efficacy and safety of dapagliflozin in pediatric heart failure".
    Int J Cardiol. 2025;438:133547.
    PubMed    
    
    
    
73. SONG Y, Shi Q, Xu C
    Comment on "The efficacy and safety of dapagliflozin in pediatric heart failure".
    Int J Cardiol. 2025 Jun 18:133537. doi: 10.1016/j.ijcard.2025.133537.
    PubMed    
    
    
    
74. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Sivadasanpillai H, et al
    Reply to "the efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes".
    Int J Cardiol. 2025 Jun 17:133525. doi: 10.1016/j.ijcard.2025.133525.
    PubMed    
    
    
    
75. MEHTA R, Sah R
    Letter to the editor: "Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection".
    Int J Cardiol. 2025 Jun 17:133535. doi: 10.1016/j.ijcard.2025.133535.
    PubMed    
    
    
    
76. D'ELIA E, Zucchetti O, Pedrazzoli F, Cereda A, et al
    Assessing palliative care needs in worsening heart failure patients: Insights from OPPORTUNITIES registry.
    Int J Cardiol. 2025;437:133491.
    PubMed     Abstract available
    
    
    
77. CEN K, Ahmedy F, Marcus M, Shukor MF, et al
    The efficacy and safety of dapagliflozin in pediatric heart failure: Interpreting causality in clinical outcomes.
    Int J Cardiol. 2025 Jun 10:133499. doi: 10.1016/j.ijcard.2025.133499.
    PubMed    
    
    
    
78. PONTIROLI AE, Ambrosio G, Leoni O, Forlani M, et al
    Heart failure and co-morbidities confer a negative prognosis in COVID-19 infection.
    Int J Cardiol. 2025 Jun 7:133492. doi: 10.1016/j.ijcard.2025.133492.
    PubMed     Abstract available
    
    
    
79. WANG Z, Wang Q, Xu H, Zhang H, et al
    Pulmonary hypertension induced right heart failure via upregulation of serum Dickkopf-1 expression.
    Int J Cardiol. 2025;437:133481.
    PubMed     Abstract available
    
    
    
80. KARSTEN M, Palermo P, Mattavelli I, Contini M, et al
    Temporal behavior of exercise oscillatory ventilation and respiratory muscle performance in patients with heart failure.
    Int J Cardiol. 2025;437:133475.
    PubMed     Abstract available
    
    
    May 2025
81. SONG Y, Li M, Zhang Z
    Comment on "impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes".
    Int J Cardiol. 2025 May 27:133441. doi: 10.1016/j.ijcard.2025.133441.
    PubMed    
    
    
    
82. YE Y, Shao WW, Yang C
    Unveiling the link between plasma proteome and cardiac function: A leap forward in heart failure research.
    Int J Cardiol. 2025 May 27:133438. doi: 10.1016/j.ijcard.2025.133438.
    PubMed    
    
    
    
83. MARTINEZ-SELLES M, Vicent L
    Reply to "Sex and clinical outcomes in new-onset heart failure".
    Int J Cardiol. 2025;435:133419.
    PubMed    
    
    
    
84. KUMAR SS, Gopalakrishnan A, Krishnamoorthy KM, Naik S, et al
    The efficacy and safety of dapagliflozin in pediatric heart failure.
    Int J Cardiol. 2025;435:133384.
    PubMed     Abstract available
    
    
    
85. CUTHBERT JJ, Lomax S, Soyiri I, Luo E, et al
    Loop diuretics, heart failure diagnosis and outcome in primary care.
    Int J Cardiol. 2025 May 18:133386. doi: 10.1016/j.ijcard.2025.133386.
    PubMed     Abstract available
    
    
    
86. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
    Response to SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025 May 15:133396. doi: 10.1016/j.ijcard.2025.133396.
    PubMed    
    
    
    
87. SALEEM D, Aamir M, Bilquees A
    Evaluating AI consistency in heart failure patient communication: A multidisciplinary critique.
    Int J Cardiol. 2025 May 11:133373. doi: 10.1016/j.ijcard.2025.133373.
    PubMed    
    
    
    
88. CHEN J, Xiao R, Gao L, Zhou Y, et al
    Real-world challenges for guideline-directed medical therapy intolerance in heart failure: A single-center prospective cohort study.
    Int J Cardiol. 2025 May 11:133367. doi: 10.1016/j.ijcard.2025.133367.
    PubMed     Abstract available
    
    
    
89. TUKKER M, Te Rijdt WP, Amin AS, Morris-Rosendahl DJ, et al
    High incidence of malignant arrhythmias and heart failure in patients with RBM20-associated cardiomyopathy: A multicenter cohort study and review of the literature.
    Int J Cardiol. 2025 May 6:133350. doi: 10.1016/j.ijcard.2025.133350.
    PubMed     Abstract available
    
    
    
90. KANI R, Miyamoto Y, Saito T, Watanabe A, et al
    Racial and regional differences in efficacy of sodium-glucose cotransporter 2 inhibitors on cardiorenal outcomes: A systematic review and meta-analysis.
    Int J Cardiol. 2025;426:133079.
    PubMed     Abstract available
    
    
    April 2025
91. YAO L, Li H, Luo S, Hao K, et al
    The miR-137/DEL-1 axis-induced apoptosis as a potential heart failure mechanism.
    Int J Cardiol. 2025 Apr 24:133308. doi: 10.1016/j.ijcard.2025.133308.
    PubMed    
    
    
    
92. VERDOIA M, Nardin M, Rognoni A
    Obesity and heart failure: Overcoming the paradox.
    Int J Cardiol. 2025;433:133304.
    PubMed    
    
    
    
93. TRIMARCHI G, Pizzino F, Paradossi U
    Inflammation in chronic heart failure: An unsolved puzzle.
    Int J Cardiol. 2025 Apr 16:133281. doi: 10.1016/j.ijcard.2025.133281.
    PubMed    
    
    
    
94. HASUMI E, Fujiu K, Chen Y, Miyamoto S, et al
    Heart failure monitoring with a single?lead electrocardiogram at home.
    Int J Cardiol. 2025 Apr 8:133203. doi: 10.1016/j.ijcard.2025.133203.
    PubMed     Abstract available
    
    
    
95. ZHANG Y, Yin X, Zhu H, Shen C, et al
    Letter to the Editor: Sex and clinical outcomes in new-onset heart failure.
    Int J Cardiol. 2025;431:133241.
    PubMed    
    
    
    March 2025
96. FAN ZX, Wu JC, Yang J
    SGLT2 inhibitors: A potential therapeutic strategy for atrial fibrillation in pulmonary arterial hypertension-induced right heart failure?
    Int J Cardiol. 2025;430:133206.
    PubMed    
    
    
    
97. RODRIGUES MM, Falcao LM
    Pathophysiology of heart failure with preserved ejection fraction in overweight and obesity - Clinical and treatment implications.
    Int J Cardiol. 2025 Mar 20:133182. doi: 10.1016/j.ijcard.2025.133182.
    PubMed     Abstract available
    
    
    
98. MOHAMED AA, Christensen DM, Mohammad M, Gluud LL, et al
    The prognostic role of Fibrosis-4 score in heart failure with reduced ejection fraction.
    Int J Cardiol. 2025;429:133174.
    PubMed     Abstract available
    
    
    
99. KURODA S, Kawamura I, Sahashi Y, Tonegawa-Kuji R, et al
    Effectiveness of rate-adaptive pacing on patients with chronotropic incompetence: Systematic review and meta-analysis of randomized controlled trials.
    Int J Cardiol. 2025;423:133022.
    PubMed     Abstract available
    
    
    
100. GODINO C, Nemola G, Sisinni A, Margonato D, et al
     Therapeutical approach of tricuspid regurgitation and right heart failure.
     Int J Cardiol. 2025;429:133163.
     PubMed     Abstract available
     
     
     
101. SZYMCZAK A, Skwarek-Dziekanowska A, Sobieszek G, Malecka-Massalska T, et al
     Comparison of the clinical value of inflammatory blood biomarkers in relation to disease severity and survival in chronic heart failure.
     Int J Cardiol. 2025;429:133165.
     PubMed     Abstract available
     
     
     
102. KESSLER EL, Dal Canto E, Diez-Benavente E, van Ommen AM, et al
     Non-classical monocytes are associated with functional markers of left ventricular diastolic dysfunction and heart failure with preserved ejection fraction.
     Int J Cardiol. 2025;429:133161.
     PubMed     Abstract available
     
     
     
103. PEIRO OM, Bardaji A, Carrasquer A, Cediel G, et al
     Growth differentiation factor 15: A biomarker to guide empagliflozin treatment in acute myocardial infarction?
     Int J Cardiol. 2025;429:133167.
     PubMed     Abstract available
     
     
     
104. PALM CL, de Wit S, Gorter TM, Rienstra M, et al
     Beyond the gut: Systemic levels of short-chain fatty acids are altered in patients with heart failure.
     Int J Cardiol. 2025;428:133124.
     PubMed     Abstract available
     
     
     
105. PANCALDI E, Adamo M, Pagnesi M, Russo G, et al
     Right heart failure and mortality in patients undergoing transcatheter tricuspid valve interventions.
     Int J Cardiol. 2025 Mar 9:133137. doi: 10.1016/j.ijcard.2025.133137.
     PubMed     Abstract available
     
     
     
106. STRACQUALURSI M, Nemola G, Santangelo G, Moscardelli S, et al
     Monitoring SGLT2 inhibition effectiveness on pulmonary systolic pressure in heart failure with reduced ejection fraction.
     Int J Cardiol. 2025;428:133136.
     PubMed     Abstract available
     
     
     
107. GAO S, Li D, Qiao B, Gong Y, et al
     Association of elevated levels of soluble transferrin receptor with left ventricular remodeling and mortality in patients with heart failure: Evidence from observational and genetic investigations.
     Int J Cardiol. 2025 Mar 6:133133. doi: 10.1016/j.ijcard.2025.133133.
     PubMed     Abstract available
     
     
     
108. VICENT L, Garcia-Cosio M, Amigo JS, Guerra JM, et al
     Sex and clinical outcomes in new-onset heart failure.
     Int J Cardiol. 2025 Mar 2:133092. doi: 10.1016/j.ijcard.2025.133092.
     PubMed     Abstract available
     
     
     
109. ABUDUKEREMU A, Chen Q, Pan Z, Liu X, et al
     Different association of HDL-C, apoA-I, and HDL-C/apoA-I with multiple outcomes in HFrEF patients.
     Int J Cardiol. 2025;422:132929.
     PubMed     Abstract available
     
     
     February 2025
110. REDDY YNV, Lee JK
     Lower than expected heart rate and exercise intolerance in heart failure - Correlation or causation?
     Int J Cardiol. 2025;427:133095.
     PubMed    
     
     
     
111. VOORDES GHD, Voors AA, Damman K
     Response to "Regarding clinical profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction".
     Int J Cardiol. 2025 Feb 25:133096. doi: 10.1016/j.ijcard.2025.133096.
     PubMed    
     
     
     
112. BESTETTI RB, Otaviano AP, Cardinalli-Neto A, Machado MN, et al
     Clinical characteristics, predictors of mortality, and outcome in patients with heart failure with mildly reduced ejection fraction secondary to Chagas cardiomyopathy.
     Int J Cardiol. 2025;426:133088.
     PubMed     Abstract available
     
     
     
113. CRAMER M, Borrelli M, Mathews L, Dewey M, et al
     Cardiac matrix-bound Nanovesicles provide insight into mechanisms of clinical heart disease progression to failure.
     Int J Cardiol. 2025;421:132892.
     PubMed     Abstract available
     
     
     
114. DELL'ERA G, Palmisano P, Bertini M, Magnano M, et al
     Real-world adoption of left bundle branch area pacing: Insights from the Conduction-System pacing Italian Network Group (C-SING).
     Int J Cardiol. 2025;421:132879.
     PubMed     Abstract available
     
     
     
115. BADAWY L, Ta Anyu A, Sadler M, Shamsi A, et al
     Long-term outcomes of hospitalised patients with de novo and acute decompensated heart failure.
     Int J Cardiol. 2025;425:133061.
     PubMed     Abstract available
     
     
     
116. HUNG TC, Chien SC, Tsao CH, Wu YW, et al
     The association of coronary microvascular dysfunction and cardiac maladaptation with clinical outcomes in heart failure with preserved ejection fraction: A prospective dynamic SPECT study.
     Int J Cardiol. 2025;425:133064.
     PubMed     Abstract available
     
     
     
117. DAVIS BJ, Kim M, Burton Y, Elman M, et al
     Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial.
     Int J Cardiol. 2025 Feb 4:133038. doi: 10.1016/j.ijcard.2025.133038.
     PubMed     Abstract available
     
     
     January 2025
118. TIAN J, Dong M, Zhang X, Lu H, et al
     Reply to letter regarding "Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study".
     Int J Cardiol. 2025;423:133011.
     PubMed    
     
     
     
119. HIPOLITO-REIS H, Guimaraes C, Elias C, Gouveia R, et al
     A new simple chronic heart failure prognostic index based on five general parameters.
     Int J Cardiol. 2025 Jan 24:133002. doi: 10.1016/j.ijcard.2025.133002.
     PubMed     Abstract available
     
     
     
120. KAGAMI K, Obokata M
     Prognostic value of cardiac output in different stages of heart failure.
     Int J Cardiol. 2025 Jan 22:133001. doi: 10.1016/j.ijcard.2025.133001.
     PubMed    
     
     
     
121. SUGIMOTO T
     The Canary in the Coal Mine: Left atrial function in heart failure.
     Int J Cardiol. 2025;423:132989.
     PubMed    
     
     
     
122. CHEN Y, Yang XH, Cheng YL, Zhou Q, et al
     Regarding clinical profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction.
     Int J Cardiol. 2025 Jan 17:132992. doi: 10.1016/j.ijcard.2025.132992.
     PubMed    
     
     
     
123. TAKEUCHI S, Kohno T, Goda A, Kohsaka S, et al
     Reply to "Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction".
     Int J Cardiol. 2025;422:132982.
     PubMed    
     
     
     
124. CHEN Z, Cheang I, Zhu X, Shi J, et al
     Validation of a non-invasive filling pressure (NIFP) device for measuring cardiac pressure and assessing congestion levels in patients with heart failure.
     Int J Cardiol. 2025 Jan 7:132973. doi: 10.1016/j.ijcard.2025.132973.
     PubMed     Abstract available
     
     
     
125. KAGAMI K, Kagiyama N, Kaneko T, Harada T, et al
     Heart failure with preserved ejection fraction in atrial functional mitral regurgitation - Insight from the REVEAL-AFMR.
     Int J Cardiol. 2025;422:132958.
     PubMed     Abstract available
     
     
     
126. AHMAD R, Khan S, Khan A, Naveed F, et al
     Critical insights on "Short-term outcomes in patients with heart failure".
     Int J Cardiol. 2025;422:132948.
     PubMed    
     
     
     
127. HARADA M, Motoike Y, Nomura Y, Nishimura A, et al
     Impact of sodium-glucose cotransporter 2 inhibitors on catheter ablation for atrial fibrillation in heart failure patients without type-2 diabetes.
     Int J Cardiol. 2025 Jan 2:132954. doi: 10.1016/j.ijcard.2024.132954.
     PubMed     Abstract available
     
     
     
128. CHIMURA M, Ohtani T, Sera F, Nakamoto K, et al
     Ratio of pulmonary artery diameter to ascending aortic diameter and its association with right ventricular failure after left ventricular assist device implantation.
     Int J Cardiol. 2025;418:132596.
     PubMed     Abstract available
     
     
     December 2024
129. FERRARI CHEN YF, Aimo A, Emdin M
     Heart failure with improved ejection fraction: A dynamic journey of recovery and possible relapse.
     Int J Cardiol. 2024;422:132944.
     PubMed    
     
     
     
130. GHAURI HF
     Letter to the editor: Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study.
     Int J Cardiol. 2024;422:132937.
     PubMed    
     
     
     
131. RICKEN KWLM, Lenselink C, Venema CS, van der Horst ICC, et al
     Left atrial strain predicts long-term heart failure outcomes after ST-elevation myocardial infarction.
     Int J Cardiol. 2024 Dec 22:132931. doi: 10.1016/j.ijcard.2024.132931.
     PubMed     Abstract available
     
     
     
132. BOGH-SORENSEN S, Dons M, Shabib A, Olsen FJ, et al
     Cardiac power and the association with heart failure and cardiovascular death in the general population.
     Int J Cardiol. 2024 Dec 21:132926. doi: 10.1016/j.ijcard.2024.132926.
     PubMed     Abstract available
     
     
     
133. PUTHENPURA MM, Wilcox J, Keane R, Demirjian S, et al
     Diuretic management protocol to improve quality and safety in managing acute heart failure in an integrated health system: An implementation science approach.
     Int J Cardiol. 2024 Dec 19:132920. doi: 10.1016/j.ijcard.2024.132920.
     PubMed     Abstract available
     
     
     
134. MANJUNATH A, Maning J, Wu T, Bryner B, et al
     Cardiac transplantation with increased-risk donors: Trends and clinical outcomes.
     Int J Cardiol. 2024;421:132887.
     PubMed     Abstract available
     
     
     
135. MINNECI C, Zucchini M, Gonzini L, Marini M, et al
     Serum uric acid, renal function and prognosis in patients with chronic heart failure and reduced ejection fraction. Insights from the Italian Network on Heart Failure.
     Int J Cardiol. 2024;421:132906.
     PubMed     Abstract available
     
     
     
136. REINHARDT M, Behnes M, Weidner K, Ayasse N, et al
     Potassium levels and short-term outcomes in heart failure with mildly reduced ejection fraction.
     Int J Cardiol. 2024 Dec 2:132878. doi: 10.1016/j.ijcard.2024.132878.
     PubMed     Abstract available
     
     
     November 2024
137. SHIMODE Y, Kitai T, Iwata K, Murai R, et al
     Impact of stress coping style on self-care behaviors and prognosis in patients with heart failure: A prospective longitudinal observational study.
     Int J Cardiol. 2024;421:132865.
     PubMed     Abstract available
     
     
     
138. HUANG L, Zhou P, Zhai M, Feng J, et al
     Incidence, progression, and outcomes of heart failure with improved ejection fraction: The added value of longitudinally assessed ejection fraction.
     Int J Cardiol. 2024 Nov 26:132759. doi: 10.1016/j.ijcard.2024.132759.
     PubMed     Abstract available
     
     
     
139. KAUR P, Ha J, Raye N, Ouwerkerk W, et al
     A systematic review of multimorbidity clusters in heart failure: Effects of methodologies.
     Int J Cardiol. 2024;420:132748.
     PubMed     Abstract available
     
     
     
140. YANG X, Tao N, Wang T, Zhang Z, et al
     The relationship between composite inflammatory indicators and short-term outcomes in patients with heart failure.
     Int J Cardiol. 2024;420:132755.
     PubMed     Abstract available
     
     
     
141. CHRISTINA A, Andrej B, Sener YZ
     GLP-1 RAs in the heart failure field: Kill many birds with one stone.
     Int J Cardiol. 2024;420:132739.
     PubMed    
     
     
     
142. NATALE F, Fusco C, Stigliani R, Golino P, et al
     Renal arterial resistance index before and after vericiguat administration: Should it be considered the fantastic five?
     Int J Cardiol. 2024;415:132467.
     PubMed     Abstract available
     
     
     
143. KAWAJI T, Hamatani Y, Kato M, Yokomatsu T, et al
     Bundle branch block patterns during atrial fibrillation rhythm for heart failure events.
     Int J Cardiol. 2024 Nov 9:132710. doi: 10.1016/j.ijcard.2024.132710.
     PubMed     Abstract available
     
     
     
144. AL'AREF SJ, Gautam N, Mansour M, Alqaisi O, et al
     Clinical parameters of death and heart failure hospitalization in biventricular systolic dysfunction assessed via cardiac magnetic resonance.
     Int J Cardiol. 2024;419:132709.
     PubMed     Abstract available
     
     
     
145. MARENZI G, Cosentino N, Imparato L, Trombara F, et al
     Temporal trends (2003-2018) of in-hospital and 30-day mortality in patients hospitalized with acute heart failure.
     Int J Cardiol. 2024 Nov 2:132693. doi: 10.1016/j.ijcard.2024.132693.
     PubMed     Abstract available
     
     
     
146. BRIGHT C, Rizvi A, Ezekwueme F, Schiff M, et al
     Impact of guideline directed medical therapy on myocardial function in adults with congenital heart disease.
     Int J Cardiol. 2024;414:132413.
     PubMed     Abstract available
     
     
     
147. BRATSETH V, Nendl A, Raju SC, Holm K, et al
     Gut dysbiosis and neutrophil extracellular traps in chronic heart failure.
     Int J Cardiol. 2024 Nov 1:132689. doi: 10.1016/j.ijcard.2024.132689.
     PubMed     Abstract available
     
     
     October 2024
148. SONG Y, Liu X
     Letter To Editor: Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
     Int J Cardiol. 2024 Oct 28:132688. doi: 10.1016/j.ijcard.2024.132688.
     PubMed    
     
     
     
149. ROWE SJ, Xiang R, Paratz ED, Takeuchi F, et al
     Left ventricular size and heart failure: A cardiac MRI assessment of 38,129 individuals from the UK Biobank.
     Int J Cardiol. 2024 Oct 26:132687. doi: 10.1016/j.ijcard.2024.132687.
     PubMed     Abstract available
     
     
     
150. CRUCIAT RC, Gazi G, Ismaiel A, Leucuta DC, et al
     Unlocking the potential of biomarkers: The promise of adrenomedullin and its precursors in diagnosing and assessing heart failure.
     Int J Cardiol. 2024 Oct 17:132659. doi: 10.1016/j.ijcard.2024.132659.
     PubMed     Abstract available
     
     
     
151. LANDER MM, Raina A
     Power is nothing without control: Optimizing left ventricular unloading with an automated Impella feedback control system.
     Int J Cardiol. 2024;413:132363.
     PubMed    
     
     
     
152. SIMONSEN JO, Modin D, Skaarup K, Djernaes K, et al
     Utilizing echocardiography and unsupervised machine learning for heart failure risk identification.
     Int J Cardiol. 2024;418:132636.
     PubMed     Abstract available
     
     
     
153. HORIUCHI Y, Wettersten N, Asami M, Yahagi K, et al
     Glucagon-like peptide-1 receptor agonists improve outcomes in individuals with type 2 diabetes with and without heart failure.
     Int J Cardiol. 2024 Oct 9:132611. doi: 10.1016/j.ijcard.2024.132611.
     PubMed     Abstract available
     
     
     
154. ALHURAYRI F, Jaynes HA, Overholser BR, Sowinski KM, et al
     Drug-induced increase in dispersion of ventricular repolarization in patients with heart failure with preserved ejection fraction.
     Int J Cardiol. 2024 Oct 9:132631. doi: 10.1016/j.ijcard.2024.132631.
     PubMed     Abstract available
     
     
     
155. HARO A, Jacob J, Rossello X, Llorens P, et al
     Impact of chronic renin-angiotensin-aldosterone inhibitors on short-term outcomes in patients with acute heart failure presenting to the emergency department. A propensity-matched analysis EAHFE cohort.
     Int J Cardiol. 2024 Oct 9:132615. doi: 10.1016/j.ijcard.2024.132615.
     PubMed     Abstract available
     
     
     
156. BERTELLI M, Ziacchi M, van Slochteren F, Rondanina E, et al
     LV cathode position in CRT recipients: How can we benefit from CMR?
     Int J Cardiol. 2024;412:132321.
     PubMed     Abstract available
     
     
     
157. SCRUTINIO D, Guida P, Carbonara R, Passantino A, et al
     Cardiac rehabilitation for old-old patients with heart failure and severe functional impairment.
     Int J Cardiol. 2024 Oct 1:132605. doi: 10.1016/j.ijcard.2024.132605.
     PubMed     Abstract available
     
     
     September 2024
158. KUIPERS S, Kappelle LJ, Greving JP, Amier RP, et al
     Sex differences in cognitive functioning in patients with heart failure.
     Int J Cardiol. 2024 Sep 27:132603. doi: 10.1016/j.ijcard.2024.132603.
     PubMed     Abstract available
     
     
     
159. TRIMARCHI G, Pizzino F
     An in-depth look at electrolytes in acute heart failure: The role of sodium-to-chloride ratio.
     Int J Cardiol. 2024;417:132585.
     PubMed    
     
     
     
160. VOORDES GHD, Voors AA, Hoegl A, Madsen CT, et al
     Clinical and proteomic profiles of chronic kidney disease in heart failure with reduced and preserved ejection fraction.
     Int J Cardiol. 2024 Sep 19:132580. doi: 10.1016/j.ijcard.2024.132580.
     PubMed     Abstract available
     
     
     
161. FERNANDO MB, Ferreira I, Lourenco P
     Admission and discharge sodium: Chloride ratio in acute heart failure - The importance of electrolytes.
     Int J Cardiol. 2024 Sep 7:132528. doi: 10.1016/j.ijcard.2024.132528.
     PubMed     Abstract available
     
     
     
162. TIAN J, Dong M, Sun X, Jia X, et al
     Vericiguat in heart failure with reduced ejection fraction patients on guideline-directed medical therapy: Insights from a 6-month real-world study.
     Int J Cardiol. 2024;417:132524.
     PubMed     Abstract available
     
     
     
163. BARLETTA V
     Promises and challenges in advanced heart failure management through CIED-based remote monitoring.
     Int J Cardiol. 2024;417:132512.
     PubMed    
     
     
     
164. HUA L
     Reply to "Assessing the clinical utility of the HFpEF nomogram: A call for broader validation".
     Int J Cardiol. 2024;410:132214.
     PubMed    
     
     
     August 2024
165. NISHIKAWA T, Ueyama J, Shimizu S, Shibata Y, et al
     Redox state of human serum albumin as a post-discharge prognostic marker in patients hospitalized for heart failure.
     Int J Cardiol. 2024 Aug 28:132497. doi: 10.1016/j.ijcard.2024.132497.
     PubMed     Abstract available
     
     
     
166. ZHANG L, Liu Z, Zeng J, Wu M, et al
     Reply to "The association between PM2.5 and heart failure".
     Int J Cardiol. 2024 Aug 28:132503. doi: 10.1016/j.ijcard.2024.132503.
     PubMed    
     
     
     
167. YAN T, Ming Y, Wang C
     The association between PM2.5 and heart failure.
     Int J Cardiol. 2024 Aug 27:132491. doi: 10.1016/j.ijcard.2024.132491.
     PubMed    
     
     
     
168. KOBAYASHI M, Yamashina A, Satomi K, Tezuka A, et al
     Adverse events associated with early initiation of Eplerenone in patients hospitalized for acute heart failure.
     Int J Cardiol. 2024;415:132477.
     PubMed     Abstract available
     
     
     
169. MUSEEDI AS, Samson R, Le Jemtel TH
     Menopause, epicardial adiposity and preserved ejection fraction heart failure.
     Int J Cardiol. 2024;415:132478.
     PubMed     Abstract available
     
     
     
170. PELLEGRINO M, Villaschi A, Gasparini G, Maccallini M, et al
     Diuretic resistance in acute heart failure: Proposal for a new urinary sodium-based definition.
     Int J Cardiol. 2024 Aug 14:132456. doi: 10.1016/j.ijcard.2024.132456.
     PubMed     Abstract available
     
     
     
171. KOYA T, Nagai T, Tada A, Nakao M, et al
     Differential impacts of self-care behavior on clinical outcomes in patients with and without recent heart failure hospitalization.
     Int J Cardiol. 2024;415:132452.
     PubMed     Abstract available
     
     
     
172. HASHIMOTO T, Yoshitake T, Suenaga T, Yamamoto S, et al
     Effectiveness of Vericiguat on right ventricle to pulmonary artery uncoupling associated with heart failure with reduced ejection fraction.
     Int J Cardiol. 2024;415:132441.
     PubMed     Abstract available
     
     
     
173. VAN DER LANDE ACMH, Feijen M, Egorova AD, Beles M, et al
     CIED-based remote monitoring in heart failure using the HeartLogic algorithm: Which patients benefit most?
     Int J Cardiol. 2024 Aug 3:132421. doi: 10.1016/j.ijcard.2024.132421.
     PubMed     Abstract available
     
     
     
174. ANSARI RAMANDI MM, Hendriks PM, Voors AA, van den Bosch AE, et al
     Bioactive adrenomedullin as a marker of congestion and disease progression in patients with a systemic right ventricle.
     Int J Cardiol. 2024;408:132107.
     PubMed     Abstract available
     
     
     July 2024
175. PALAGINI L, Gentile F, Emdin M
     Anxiety, depression and chronic heart failure: Bad companions getting worse over time.
     Int J Cardiol. 2024 Jul 31:132409. doi: 10.1016/j.ijcard.2024.132409.
     PubMed    
     
     
     
176. TSENG CH
     Metformin-associated lactic acidosis and mortality in type 2 diabetes patients hospitalized with heart failure and/or acute coronary syndrome: A neglected clinical scenario and the potential role of insulin.
     Int J Cardiol. 2024 Jul 30:132400. doi: 10.1016/j.ijcard.2024.132400.
     PubMed    
     
     
     
177. ABEL N, Schupp T, Schmitt A, Reinhardt M, et al
     Left ventricular diastolic dysfunction in patients with heart failure with mildly reduced ejection fraction.
     Int J Cardiol. 2024 Jul 28:132386. doi: 10.1016/j.ijcard.2024.132386.
     PubMed     Abstract available
     
     
     
178. HAO G, Chen X, Fang Z, He Y, et al
     Association between prescription opioid use and heart failure: Cohort studies and Mendelian randomization analysis.
     Int J Cardiol. 2024 Jul 27:132404. doi: 10.1016/j.ijcard.2024.132404.
     PubMed     Abstract available
     
     
     
179. KELLY B, Thorup L, Telinius N, Mohanakumar S, et al
     Lymphatic morphology and function in chronic right heart failure due to secondary tricuspid valve regurgitation.
     Int J Cardiol. 2024;413:132399.
     PubMed     Abstract available
     
     
     
180. D'ERRIGO P, De Luca L, Rosato S, Giordani B, et al
     Prognostic role of coronary angiography and revascularization in patients firstly admitted for heart failure in Italy.
     Int J Cardiol. 2024 Jul 23:132369. doi: 10.1016/j.ijcard.2024.132369.
     PubMed     Abstract available
     
     
     
181. ANDREA B, Anna D, Daniele B, Angelica C, et al
     H(2)FPEF and HFA-PEFF scores performance and the additional value of cardiac structure and function in patients with atrial fibrillation.
     Int J Cardiol. 2024 Jul 18:132385. doi: 10.1016/j.ijcard.2024.132385.
     PubMed     Abstract available
     
     
     
182. FU K, Yang Z, Wang N, Dong Y, et al
     Recurrence of left ventricular systolic dysfunction and its risk factors in heart failure with improved ejection fraction patients receiving guideline-directed medical therapy: A trajectory analysis based on echocardiography.
     Int J Cardiol. 2024 Jul 17:132370. doi: 10.1016/j.ijcard.2024.132370.
     PubMed     Abstract available
     
     
     
183. HUANG H, Fu B, Long T, Yu Y, et al
     Implication of geriatric nutritional risk index on treatment response and long-term prognosis in patients with cardiac resynchronization therapy.
     Int J Cardiol. 2024;407:132064.
     PubMed     Abstract available
     
     
     
184. PINTALHAO M, Vasques-Novoa F, Barros AS, Lourenco P, et al
     Prognostic association of circulating relaxin-2 in acute heart failure.
     Int J Cardiol. 2024 Jul 11:132358. doi: 10.1016/j.ijcard.2024.132358.
     PubMed     Abstract available
     
     
     
185. BLASCO-TURRION S, Crespo-Leiro MG, Trenado VD, Hion PLC, et al
     Structural heart transcatheter interventions in orthotopic cardiac transplant and left ventricular assist devices recipients: A nationwide study.
     Int J Cardiol. 2024 Jul 9:132340. doi: 10.1016/j.ijcard.2024.132340.
     PubMed     Abstract available
     
     
     
186. ZHANG L, Liu Z, Zeng J, Wu M, et al
     Long-term effects of air quality on hospital readmission for heart failure in patients with acute myocardial infarction.
     Int J Cardiol. 2024 Jul 6:132344. doi: 10.1016/j.ijcard.2024.132344.
     PubMed     Abstract available
     
     
     
187. DE PONTI C, Bonaventura A
     Bioelectrical impedance analysis for early recognition of fluid congestion in heart failure: Is it the best tool?
     Int J Cardiol. 2024 Jul 5:132314. doi: 10.1016/j.ijcard.2024.132314.
     PubMed    
     
     
     
188. MEGURO T
     Diversity in heart failure management: Quo Vadis guideline-directed medical therapy?
     Int J Cardiol. 2024 Jul 5:132325. doi: 10.1016/j.ijcard.2024.132325.
     PubMed    
     
     
     
189. DE ALMEIDA PINHO I, Pimentel MJ, Oliveira C, Matos MI, et al
     Office- versus home-based evaluation of quality of life in heart failure with reduced ejection fraction: A randomized study.
     Int J Cardiol. 2024 Jul 4:132341. doi: 10.1016/j.ijcard.2024.132341.
     PubMed     Abstract available
     
     
     
190. TERSALVI G, Bossard M, Aeschbacher S, Wiencierz A, et al
     Prevalence and outcomes of heart failure phenotypes in patients with atrial fibrillation.
     Int J Cardiol. 2024 Jul 2:132320. doi: 10.1016/j.ijcard.2024.132320.
     PubMed     Abstract available
     
     
     
191. ALBULUSHI A
     Assessing the clinical utility of the HFpEF nomogram: A call for broader validation.
     Int J Cardiol. 2024;406:132038.
     PubMed    
     
     
     
192. NOGIMORI Y, Sato K, Takamizawa K, Ogawa Y, et al
     Prediction of adverse cardiovascular events in children using artificial intelligence-based electrocardiogram.
     Int J Cardiol. 2024;406:132019.
     PubMed     Abstract available
     
     
     June 2024
193. ESPERSEN C, Campbell RT, Claggett BL, Biering-Sorensen T, et al
     Reply to: Instrumental outcome modifiers to be considered among patients with acute heart failure.
     Int J Cardiol. 2024 Jun 29:132310. doi: 10.1016/j.ijcard.2024.132310.
     PubMed    
     
     
     
194. TIMOTEO AT, Barbas Albuquerque F, Lacerda Teixeira B
     Pericardium, epicardial adipose tissue, and heart failure with preserved ejection fraction: Pathophysiology, quantification and treatment target.
     Int J Cardiol. 2024;412:132303.
     PubMed     Abstract available
     
     
     
195. ABDIN A, Bohm M, Shahim B, Karlstrom P, et al
     Heart failure with preserved ejection fraction epidemiology, pathophysiology, diagnosis and treatment strategies.
     Int J Cardiol. 2024 Jun 27:132304. doi: 10.1016/j.ijcard.2024.132304.
     PubMed     Abstract available
     
     
     
196. AIMO A, Arzilli C, Castiglione V, Morfino P, et al
     Safety and efficacy of levosimendan in patients with cardiac amyloidosis.
     Int J Cardiol. 2024;405:131963.
     PubMed     Abstract available
     
     
     
197. FORTUNI F, Tavazzi L, Ciliberti G
     Digital health in heart failure: Empowering physicians to enhance patient care.
     Int J Cardiol. 2024 Jun 15:132261. doi: 10.1016/j.ijcard.2024.132261.
     PubMed    
     
     
     
198. FERREIRA JP, Zannad F, Solomon SD
     Reply to the letter entitled "Inflammation in Heart Failure with Preserved Ejection Fraction: A Bystander or A Participant?" by Zhong M and Yan X.
     Int J Cardiol. 2024 Jun 14:132278. doi: 10.1016/j.ijcard.2024.132278.
     PubMed    
     
     
     
199. KAMAR SA, Oostdijk B, Andrzejczyk K, Constantinescu A, et al
     Temporal evolution of anxiety and depression in chronic heart failure and its association with clinical outcome.
     Int J Cardiol. 2024 Jun 14:132274. doi: 10.1016/j.ijcard.2024.132274.
     PubMed     Abstract available
     
     
     
200. DAUNGSUPAWONG H, Wiwanitkit V
     Comment on "Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure: Doi: 10.1016/j.ijcard.2024.132115".
     Int J Cardiol. 2024;410:132242.
     PubMed    
     
     
     
201. KRITTAYAPHONG R, Yingchoncharoen T, Puwanant S, Boonyapiphat T, et al
     Reassessing heart failure therapy in Thailand: Patient insights and treatment outcomes from the Thai heart failure registry.
     Int J Cardiol. 2024 Jun 4:132235. doi: 10.1016/j.ijcard.2024.132235.
     PubMed     Abstract available
     
     
     
202. CAI Q, Li Q, Zhong S, Chen M, et al
     Ultrasound-targeted microbubble destruction rapidly improves left ventricular function in rats with ischemic cardiac dysfunction.
     Int J Cardiol. 2024;404:131943.
     PubMed     Abstract available
     
     
     
203. NABESHIMA Y, Tanaka A, Node K
     Sweet relationship between SGLT2 inhibition and heart failure.
     Int J Cardiol. 2024;410:132223.
     PubMed    
     
     
     May 2024
204. LEE S, Battumur B, Lee JE, Park SH, et al
     Assessing lung fluid status using noninvasive bioelectrical impedance analysis in patients with acute heart failure: A pilot study.
     Int J Cardiol. 2024;409:132205.
     PubMed     Abstract available
     
     
     
205. TADA A, Nagai T, Anzai T
     Is growth differentiation factor-15 a useful biomarker for chronic heart failure across body size?
     Int J Cardiol. 2024 May 23:132204. doi: 10.1016/j.ijcard.2024.132204.
     PubMed    
     
     
     
206. TAKEUCHI S, Kohno T, Goda A, Shiraishi Y, et al
     Renin-angiotensin system inhibitors for patients with mild or moderate chronic kidney disease and heart failure with mildly reduced or preserved ejection fraction.
     Int J Cardiol. 2024;409:132190.
     PubMed     Abstract available
     
     
     
207. LIU H, Xu G
     SNHG1/miR-15a-5p/Drd5: A potential mechanism for treating heart failure.
     Int J Cardiol. 2024;409:132188.
     PubMed    
     
     
     
208. TADAFUMI S
     Pulmonary fluid redistribution during exercise and recovery in chronic heart failure.
     Int J Cardiol. 2024 May 14:132173. doi: 10.1016/j.ijcard.2024.132173.
     PubMed    
     
     
     
209. KAWAI A, Nagatomo Y, Yukino-Iwashita M, Ikegami Y, et al
     Supra-normal and mildly reduced ejection fraction in women -An overlooked vulnerable subpopulation in heart failure.
     Int J Cardiol. 2024 May 12:132166. doi: 10.1016/j.ijcard.2024.132166.
     PubMed     Abstract available
     
     
     
210. FEDERICA P, Samantha B, Davide A, Lucia C, et al
     Serum uric acid to eGFR ratio correlates with adverse outcomes in elderly hospitalized for acute heart failure.
     Int J Cardiol. 2024 May 11:132160. doi: 10.1016/j.ijcard.2024.132160.
     PubMed     Abstract available
     
     
     
211. HUNG KC, Chao CT
     Instrumental outcome modifiers to be considered among patients with acute heart failure.
     Int J Cardiol. 2024;408:132145.
     PubMed    
     
     
     
212. ZHONG M, Yan X
     Inflammation in heart failure with preserved ejection fraction: A bystander or a participant?
     Int J Cardiol. 2024;408:132144.
     PubMed    
     
     
     
213. COLLUOGLU IT, Celik A, Ata N, Ural D, et al
     Deciphering mortality risk of diabetes medications in heart failure patients with diabetes mellitus under triple guideline-directed medical therapy.
     Int J Cardiol. 2024;407:132109.
     PubMed     Abstract available
     
     
     
214. ALBULUSHI A, Al Kindi DI, Moawwad N, Kamel AM, et al
     Digital health technologies in enhancing patient and caregiver engagement in heart failure management: Opportunities and challenges.
     Int J Cardiol. 2024 May 2:132116. doi: 10.1016/j.ijcard.2024.132116.
     PubMed     Abstract available
     
     
     
215. SPERLONGANO S, Benfari G, Ilardi F, Lisi M, et al
     Role of speckle tracking echocardiography beyond current guidelines in cardiac resynchronization therapy.
     Int J Cardiol. 2024;402:131885.
     PubMed     Abstract available
     
     
     April 2024
216. KOZAILY E, Geagea M, Akdogan ER, Atkins J, et al
     Accuracy and consistency of online large language model-based artificial intelligence chat platforms in answering patients' questions about heart failure.
     Int J Cardiol. 2024 Apr 30:132115. doi: 10.1016/j.ijcard.2024.132115.
     PubMed     Abstract available
     
     
     
217. TERAMOTO K, Nochioka K, Sakata Y, Kato ET, et al
     Growth differentiation factor-1?5 and metabolic features in chronic heart failure: Insights from the SUPPORT Trial -GDF15 across the BMI spectrum.
     Int J Cardiol. 2024 Apr 23:132093. doi: 10.1016/j.ijcard.2024.132093.
     PubMed     Abstract available
     
     
     
218. CHEW-HARRIS J, Frampton C, Greer C, Appleby S, et al
     Prognostic performance of soluble urokinase plasminogen activator receptor for heart failure or mortality in Western and Asian patients with acute breathlessness.
     Int J Cardiol. 2024 Apr 19:132071. doi: 10.1016/j.ijcard.2024.132071.
     PubMed     Abstract available
     
     
     
219. PEZZUTO B, Contini M, Berna G, Galotta A, et al
     Dynamic trend of lung fluid movement during exercise in heart failure: From lung imaging to alveolar-capillary membrane function.
     Int J Cardiol. 2024 Apr 19:132041. doi: 10.1016/j.ijcard.2024.132041.
     PubMed     Abstract available
     
     
     
220. HONG Y, Gao Z, Wei H, Wei Y, et al
     Bi-directional association of body size and composition with heart failure: A Mendelian randomization study.
     Int J Cardiol. 2024 Apr 19:132069. doi: 10.1016/j.ijcard.2024.132069.
     PubMed     Abstract available
     
     
     
221. JONG CB, Lu TS, Chen JW
     Reply to comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Apr 10:132031. doi: 10.1016/j.ijcard.2024.132031.
     PubMed    
     
     
     
222. ESPERSEN C, Campbell RT, Claggett BL, Lewis EF, et al
     Predictors of heart failure readmission and all-cause mortality in patients with acute heart failure.
     Int J Cardiol. 2024 Apr 8:132036. doi: 10.1016/j.ijcard.2024.132036.
     PubMed     Abstract available
     
     
     
223. GLINGE C, Rossetti S, Oestergaard LB, Stampe NK, et al
     Familial clustering of unexplained heart failure - A Danish nationwide cohort study.
     Int J Cardiol. 2024 Apr 5:132028. doi: 10.1016/j.ijcard.2024.132028.
     PubMed     Abstract available
     
     
     
224. NAKAO M, Nagai T, Anzai T
     Iron supplementation is a residual piece of management in Asian patients with heart failure?
     Int J Cardiol. 2024 Apr 4:132014. doi: 10.1016/j.ijcard.2024.132014.
     PubMed    
     
     
     
225. DE MICHIELI L, Stoppa G, Sinigiani G, Previato L, et al
     Hospitalization-based epidemiology of systemic and cardiac amyloidosis in the Veneto Region, Italy.
     Int J Cardiol. 2024;400:131804.
     PubMed     Abstract available
     
     
     
226. DE SA MARCHI MF, van den Dorpel M, Calomeni P, Chatterjee S, et al
     Comparative analysis of different risk prediction tools after mitral Transcatheter edge-to-edge repair.
     Int J Cardiol. 2024;400:131768.
     PubMed     Abstract available
     
     
     
227. GARCIA-MOLL X, Lopez L
     Safety of sacubitril/valsartan among older adults. Where real world data meet clinical trials results.
     Int J Cardiol. 2024;400:131706.
     PubMed    
     
     
     March 2024
228. CHENG Y, Zhang Q
     Comment on "Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome".
     Int J Cardiol. 2024 Mar 26:131979. doi: 10.1016/j.ijcard.2024.131979.
     PubMed    
     
     
     
229. YAO L, Gong X, Liu Y, Hao K, et al
     The miR-195-3p/BDNF axis is a promising therapeutic for heart failure.
     Int J Cardiol. 2024 Mar 22:131991. doi: 10.1016/j.ijcard.2024.131991.
     PubMed    
     
     
     
230. CARIGI S, Gentile P, Gori M, Tinti D, et al
     Clinical characteristics, treatment, trajectories and outcome of patients with dilated cardiomyopathy in a national heart failure registry.
     Int J Cardiol. 2024 Mar 19:131986. doi: 10.1016/j.ijcard.2024.131986.
     PubMed     Abstract available
     
     
     
231. KARAKITSOS P, Mylonas KS
     Raw data were not disclosed in 95% of PubMed-indexed heart failure meta-analyses in 2021: A systematic analysis of transparency.
     Int J Cardiol. 2024 Mar 19:131987. doi: 10.1016/j.ijcard.2024.131987.
     PubMed     Abstract available
     
     
     
232. HUA L, Zhang R, Chen R, Shao W, et al
     A nomogram for predicting the risk of heart failure with preserved ejection fraction.
     Int J Cardiol. 2024 Mar 18:131973. doi: 10.1016/j.ijcard.2024.131973.
     PubMed     Abstract available
     
     
     
233. LUND-ANDERSEN C, Yafasova A, Hofsten D, Thune JJ, et al
     Association between QRS shortening and mortality after cardiac resynchronization therapy: Results from the DANISH study.
     Int J Cardiol. 2024;399:131700.
     PubMed     Abstract available
     
     
     
234. CHAO-CHEN L
     Letter to the Editor: "Changes in walking speed 6 months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure".
     Int J Cardiol. 2024 Mar 13:131958. doi: 10.1016/j.ijcard.2024.131958.
     PubMed    
     
     
     
235. BACKHAUS SJ, Schulz A, Lange T, Schmidt-Schweda LS, et al
     Prognostic and diagnostic implications of impaired rest and exercise-stress left atrial compliance in heart failure with preserved ejection fraction: Insights from the HFpEF stress trial.
     Int J Cardiol. 2024 Mar 11:131949. doi: 10.1016/j.ijcard.2024.131949.
     PubMed     Abstract available
     
     
     
236. BARSSOUM K, Abumoawad A, Chowdhury M, Agrawal A, et al
     Perioperative outcomes of hypertrophic cardiomyopathy: An insight from the National Readmission Database.
     Int J Cardiol. 2024;398:131601.
     PubMed     Abstract available
     
     
     February 2024
237. KIKO T, Aoki T
     The relationship between duration of delirium and clinical outcomes in patients with acute heart failure.
     Int J Cardiol. 2024 Feb 23:131902. doi: 10.1016/j.ijcard.2024.131902.
     PubMed    
     
     
     
238. LUO Z, Gong X, Liu Y, Hao K, et al
     Mitochondrial dysfunction due to miR-210/Drd5/ROS axis is a potential mechanism of heart failure.
     Int J Cardiol. 2024 Feb 20:131897. doi: 10.1016/j.ijcard.2024.131897.
     PubMed    
     
     
     
239. GUAZZI M, Crisci G
     Exercise mean PAP to CO relationship: An insightful endpoint for testing therapeutic interventions in heart failure.
     Int J Cardiol. 2024 Feb 20:131899. doi: 10.1016/j.ijcard.2024.131899.
     PubMed    
     
     
     
240. SIM DKL, Mittal S, Zhang J, Hung CL, et al
     Expert recommendations for the management of iron deficiency in patients with heart failure in Asia.
     Int J Cardiol. 2024 Feb 19:131890. doi: 10.1016/j.ijcard.2024.131890.
     PubMed     Abstract available
     
     
     
241. LERMAN TT, Greenberg N, Fishman B, Goldman A, et al
     The real-world safety of sacubitril / valsartan among older adults (>/=75): A pharmacovigilance study from the FDA data.
     Int J Cardiol. 2024;397:131613.
     PubMed     Abstract available
     
     
     
242. LV L, Chen Q, Lu J, Zhao Q, et al
     Potential regulatory role of epigenetic modifications in aging-related heart failure.
     Int J Cardiol. 2024 Feb 13:131858. doi: 10.1016/j.ijcard.2024.131858.
     PubMed     Abstract available
     
     
     
243. ISMAIL TF
     Understanding heart failure and cardiomyopathy in Africa: Insights from cardiovascular magnetic resonance.
     Int J Cardiol. 2024 Feb 12:131847. doi: 10.1016/j.ijcard.2024.131847.
     PubMed    
     
     
     
244. HAGE C, Lund LH
     Inflammation and myeloperoxidase - The next treatment targets in heart failure?
     Int J Cardiol. 2024 Feb 5:131834. doi: 10.1016/j.ijcard.2024.131834.
     PubMed    
     
     
     
245. LI G, Liu X, Long A, Feng J, et al
     An inducible mouse model of heart failure targeted to cardiac Drd5 deficiency detonating mitochondrial oxidative stress.
     Int J Cardiol. 2024;396:131560.
     PubMed    
     
     
     
246. IANNACCONE M, Barbero U, Franchin L, Montabone A, et al
     Comparison of mid-term mortality after surgical, supported or unsupported percutaneous revascularization in patients with severely reduced ejection fraction: A direct and network meta-analysis of adjusted observational studies and randomized-controlle
     Int J Cardiol. 2024;396:131428.
     PubMed     Abstract available
     
     
     January 2024
247. FERREIRA JP, Claggett BL, Liu J, Sharma A, et al
     High-sensitivity C-reactive protein in heart failure with preserved ejection fraction: Findings from TOPCAT.
     Int J Cardiol. 2024 Jan 31:131818. doi: 10.1016/j.ijcard.2024.131818.
     PubMed     Abstract available
     
     
     
248. XU L, Chen Y, Chen S, Wang G, et al
     Relationship between resting heart rate and long-term outcomes in stabilized patients with myocardial infarction: A prospective community-based cohort study.
     Int J Cardiol. 2024 Jan 24:131811. doi: 10.1016/j.ijcard.2024.131811.
     PubMed     Abstract available
     
     
     
249. MIGLIORE F, Schiavone M, Pittorru R, Forleo GB, et al
     Left ventricular assist device in the presence of subcutaneous implantable cardioverter defibrillator: Data from a multicenter experience.
     Int J Cardiol. 2024 Jan 23:131807. doi: 10.1016/j.ijcard.2024.131807.
     PubMed     Abstract available
     
     
     
250. YAMAGUCHI N, Hirata Y, Nishio S, Takahashi T, et al
     Pulmonary pressure-flow responses to exercise in heart failure treated with angiotensin receptor neprilysin inhibitor.
     Int J Cardiol. 2024 Jan 20:131789. doi: 10.1016/j.ijcard.2024.131789.
     PubMed     Abstract available
     
     
     
251. MUSUMECI B, Tini G, Biagini E, Merlo M, et al
     Clinical characteristics and outcome of end stage hypertrophic cardiomyopathy: Role of age and heart failure phenotypes.
     Int J Cardiol. 2024 Jan 18:131784. doi: 10.1016/j.ijcard.2024.131784.
     PubMed     Abstract available
     
     
     
252. KANG DW, Kang SH, Lee K, Nam K, et al
     Comparative efficacy of vericiguat to sacubitril/valsartan for patients with heart failure reduced ejection fraction: Systematic review and network meta-analysis.
     Int J Cardiol. 2024 Jan 17:131786. doi: 10.1016/j.ijcard.2024.131786.
     PubMed     Abstract available
     
     
     
253. CHERBI M, Bouisset F, Bonnefoy E, Lamblin N, et al
     Characteristics, management, and mid-term prognosis of older adults with cardiogenic shock admitted to intensive care units: Insights from the FRENSHOCK registry.
     Int J Cardiol. 2024;395:131578.
     PubMed     Abstract available
     
     
     
254. MUROKE V, Jalanko M, Haukka J, Anttila V, et al
     Long-term outcome after surgical correction of sinus venosus defect in a nationwide register-based cohort study.
     Int J Cardiol. 2024;395:131433.
     PubMed     Abstract available
     
     
     
255. HANADA S, Adachi T, Iwatsu K, Kamisaka K, et al
     Changes in walking speed 6?months after discharge may be more sensitive to subsequent prognosis than handgrip strength in patients hospitalized for heart failure.
     Int J Cardiol. 2024 Jan 11:131778. doi: 10.1016/j.ijcard.2024.131778.
     PubMed     Abstract available
     
     
     
256. QUATTRONE F, Aimo A, Zuccarino S, Morelli MS, et al
     Unmet needs in end-of-life care for heart failure patients.
     Int J Cardiol. 2024 Jan 10:131750. doi: 10.1016/j.ijcard.2024.131750.
     PubMed     Abstract available
     
     
     
257. AIKAWA Y, Ogata S, Honda S, Nagai T, et al
     Prolonged delirium during hospitalization is associated with worse long-term and short-term outcomes in patients with acute heart failure.
     Int J Cardiol. 2024 Jan 10:131776. doi: 10.1016/j.ijcard.2024.131776.
     PubMed     Abstract available
     
     
     
258. PASTORE MC, Vannuccini F, Mandoli GE, Lisi M, et al
     Myocardial work and left heart deformation parameters across primary mitral regurgitation severity.
     Int J Cardiol. 2024 Jan 9:131772. doi: 10.1016/j.ijcard.2024.131772.
     PubMed     Abstract available
     
     
     
259. SRAYA R, Amsalem I, Carasso S, Gilad O, et al
     Mitral valve gradient changes associate with outcomes of patients undergoing transcatheter edge-to-edge repair.
     Int J Cardiol. 2024 Jan 9:131766. doi: 10.1016/j.ijcard.2024.131766.
     PubMed     Abstract available
     
     
     
260. MIYOSHI T
     A novel genetically engineered mouse model for investigating heart failure mechanisms and therapeutic interventions.
     Int J Cardiol. 2024 Jan 3:131703. doi: 10.1016/j.ijcard.2023.131703.
     PubMed    
     
     
     
261. EGBE AC, Abozied O, Miranda WR, Younis A, et al
     Prognostic role of inferior vena collapsibility index in congenital heart disease: A validation study.
     Int J Cardiol. 2024;394:131399.
     PubMed     Abstract available
     
     
     December 2023
262. SAEED S, Bleie O
     Prognostic validation of first-phase ejection fraction in patients with heart failure: A new piece of evidence.
     Int J Cardiol. 2023 Dec 31:131692. doi: 10.1016/j.ijcard.2023.131692.
     PubMed    
     
     
     
263. TAN Z, Liu Y, Hong K
     The association between serum chloride and mortality in ICU patients with heart failure: The impact of bicarbonate.
     Int J Cardiol. 2023 Dec 22:131672. doi: 10.1016/j.ijcard.2023.131672.
     PubMed     Abstract available
     
     
     
264. ADAMO M, Pagnesi M, Di Pasquale M, Ravera A, et al
     Differential biomarker expression in heart failure patients with and without mitral regurgitation: Insights from BIOSTAT-CHF.
     Int J Cardiol. 2023 Dec 21:131664. doi: 10.1016/j.ijcard.2023.131664.
     PubMed     Abstract available
     
     
     
265. WONG CN, Gui XY, Rabkin SW
     Myeloperoxidase, carnitine, and derivatives of reactive oxidative metabolites in heart failure with preserved versus reduced ejection fraction: A meta-analysis.
     Int J Cardiol. 2023 Dec 13:131657. doi: 10.1016/j.ijcard.2023.131657.
     PubMed     Abstract available
     
     
     
266. OZLEK B
     Tricuspid regurgitation and heart failure with preserved ejection fraction: An enigma in cardiology practice.
     Int J Cardiol. 2023 Dec 10:131649. doi: 10.1016/j.ijcard.2023.131649.
     PubMed    
     
     
     
267. HU H, Yang J
     Heart failure complicated by atrial fibrillation: How to make better choices for anticoagulation?
     Int J Cardiol. 2023 Dec 6:131644. doi: 10.1016/j.ijcard.2023.131644.
     PubMed    
     
     
     
268. ELIA E, Bruno F, Crimi G, Wanha W, et al
     Gender differences in the development of heart failure after acute coronary syndrome: Insight from the CORALYS registry.
     Int J Cardiol. 2023 Dec 5:131622. doi: 10.1016/j.ijcard.2023.131622.
     PubMed     Abstract available
     
     
     
269. GAO Y, Liu M, Ju Z, Wang H, et al
     Entropy as a novel predictor of cardiovascular events in patients with left ventricular noncompaction.
     Int J Cardiol. 2023;392:131279.
     PubMed     Abstract available
     
     
     November 2023
270. JIN C, Chen G, Zhao C, Wu Y, et al
     First-phase ejection fraction to predict adverse outcomes in patients with heart failure.
     Int J Cardiol. 2023 Nov 30:131612. doi: 10.1016/j.ijcard.2023.131612.
     PubMed     Abstract available
     
     
     
271. CHOI HM, Hwang IC, Choi HJ, Yoon YE, et al
     Irreversible myocardial injury attenuates the benefits of sacubitril/valsartan in heart failure patients.
     Int J Cardiol. 2023 Nov 27:131611. doi: 10.1016/j.ijcard.2023.131611.
     PubMed     Abstract available
     
     
     
272. MORONI F, Corna G, Del Buono MG, Golino M, et al
     Impact of C-reactive protein levels and role of anakinra in patients with ST-elevation myocardial infarction.
     Int J Cardiol. 2023 Nov 26:131610. doi: 10.1016/j.ijcard.2023.131610.
     PubMed     Abstract available
     
     
     
273. TAYAL B, Rorth R, Kristensen SL, Wissenberg M, et al
     Comparative outcomes in patients with preexisting heart failure to those without heart failure after out-of-hospital cardiac arrest: A nationwide registry study.
     Int J Cardiol. 2023 Nov 18:131595. doi: 10.1016/j.ijcard.2023.131595.
     PubMed     Abstract available
     
     
     
274. ALEXANDRINO FB, Faaborg-Andersen CC, da Silva-de Abreu A
     Anticoagulation in patients with atrial fibrillation and heart failure: More than meets the eye?
     Int J Cardiol. 2023 Nov 16:131591. doi: 10.1016/j.ijcard.2023.131591.
     PubMed    
     
     
     
275. LAU ATC, DiDomenico RJ, Kim K
     Cost-effectiveness of systematic screening and treatment of transthyretin amyloid cardiomyopathy (ATTR-CM) in patients with Heart failure with preserved ejection fraction (HFpEF) in United States.
     Int J Cardiol. 2023 Nov 16:131598. doi: 10.1016/j.ijcard.2023.131598.
     PubMed     Abstract available
     
     
     
276. ROSSI VA, Laptseva N, Nebunu D, Haider T, et al
     Impaired retinal micro-vascular function in patients with atrial fibrillation.
     Int J Cardiol. 2023 Nov 16:131592. doi: 10.1016/j.ijcard.2023.131592.
     PubMed     Abstract available
     
     
     
277. D'AMARIO D, Laborante R, Bianchini E, Galli M, et al
     Statins as preventive therapy for anthracycline cardiotoxicity: a meta-analysis of randomized controlled trials.
     Int J Cardiol. 2023;391:131219.
     PubMed     Abstract available
     
     
     
278. CHAVALI S, Barua S, Adji A, Robson D, et al
     Safety and tolerability of sodium-glucose cotransporter-2 inhibitors in bridge-to-transplant patients supported with centrifugal-flow left ventricular assist devices.
     Int J Cardiol. 2023;391:131259.
     PubMed     Abstract available
     
     
     
279. LI ZH, Zhong WF, Qiu CS, Yang P, et al
     Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study.
     Int J Cardiol. 2023 Nov 5:131567. doi: 10.1016/j.ijcard.2023.131567.
     PubMed     Abstract available
     
     
     
280. DORES H, Toste A, Cardim N
     Hypertrophic cardiomyopathy in patients with a normal electrocardiogram: A view from the east side of the Atlantic Ocean.
     Int J Cardiol. 2023;390:131260.
     PubMed     Abstract available
     
     
     October 2023
281. MASE M, Rossi M, Setti M, Barbati G, et al
     Applicability and performance of heart failure prognostic scores in dilated cardiomyopathy: The real-world experience of an Italian referral center for cardiomyopathies.
     Int J Cardiol. 2023 Oct 29:131562. doi: 10.1016/j.ijcard.2023.131562.
     PubMed     Abstract available
     
     
     
282. KOSEOGLU FD, Ozlek B
     Hemoglobin to red cell distribution width ratio in patients with heart failure with preserved ejection fraction.
     Int J Cardiol. 2023 Oct 27:131556. doi: 10.1016/j.ijcard.2023.131556.
     PubMed    
     
     
     
283. SERAFIN A, Jasic-Szpak E, Marwick TH, Przewlocka-Kosmala M, et al
     Contribution of reduced skeletal muscle perfusion reserve to exercise intolerance in heart failure with preserved ejection fraction.
     Int J Cardiol. 2023 Oct 21:131553. doi: 10.1016/j.ijcard.2023.131553.
     PubMed     Abstract available
     
     
     
284. SERI A, Rabadi A, Baral N, Andi K, et al
     Prevalence of respiratory failure and use of mechanical ventilation in heart failure patients undergoing left atrial appendage occlusion device implantation.
     Int J Cardiol. 2023 Oct 21:131552. doi: 10.1016/j.ijcard.2023.131552.
     PubMed     Abstract available
     
     
     
285. ZITO A, Restivo A, D'Amario D
     Reply to "Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis".
     Int J Cardiol. 2023 Oct 20:131545. doi: 10.1016/j.ijcard.2023.131545.
     PubMed    
     
     
     
286. ANSARI RAMANDI MM, Yarmohammadi H, Gareb B, Voors AA, et al
     Long-term outcome of patients with transposition of the great arteries and a systemic right ventricle: A systematic review and meta-analysis.
     Int J Cardiol. 2023;389:131159.
     PubMed     Abstract available
     
     
     
287. JAIN SS, Yu J, Arnott C, Neal B, et al
     Treatment effect of canagliflozin for patients on therapy for heart failure: Pooled analysis of the CANVAS program and CREDENCE trial.
     Int J Cardiol. 2023 Oct 14:131444. doi: 10.1016/j.ijcard.2023.131444.
     PubMed     Abstract available
     
     
     
288. IMANISHI J, Iwasaki M, Ujiro S, Nakano T, et al
     Accuracy of lung ultrasound examinations of residual congestion performed by novice residents in patients with acute heart failure.
     Int J Cardiol. 2023 Oct 14:131446. doi: 10.1016/j.ijcard.2023.131446.
     PubMed     Abstract available
     
     
     
289. LEONARDI D, Bursi F, Fanti D, Dotto A, et al
     Outpatient tricuspid regurgitation in the community: Clinical context and outcome.
     Int J Cardiol. 2023 Oct 14:131443. doi: 10.1016/j.ijcard.2023.131443.
     PubMed     Abstract available
     
     
     
290. MOCKEL M, Pudasaini S, Baberg HT, Levenson B, et al
     Oral anticoagulation in heart failure complicated by atrial fibrillation: A nationwide routine data study.
     Int J Cardiol. 2023 Oct 10:131434. doi: 10.1016/j.ijcard.2023.131434.
     PubMed     Abstract available
     
     
     
291. ROONGSANGMANOON W, Wongsoasup A, Chichareon P, Suwannasom P, et al
     Validation of the academic research consortium high bleeding risk definition in Thai PCI registry.
     Int J Cardiol. 2023;388:131167.
     PubMed     Abstract available
     
     
     September 2023
292. ZHENG H, Yin Z, Luo X, Zhou Y, et al
     Associations between systemic immunity-inflammation index and heart failure: Evidence from the NHANES 1999-2018.
     Int J Cardiol. 2023 Sep 26:131400. doi: 10.1016/j.ijcard.2023.131400.
     PubMed     Abstract available
     
     
     
293. FONDERICO C, Pergola V, Faccenda D, Salucci A, et al
     Impact of sacubitril/valsartan and gliflozins on cardiac resynchronization therapy response in ischemic and non-ischemic heart failure patients.
     Int J Cardiol. 2023 Sep 23:131391. doi: 10.1016/j.ijcard.2023.131391.
     PubMed     Abstract available
     
     
     
294. BAUMHOVE L, Bomer N, Tromp J, van Essen BJ, et al
     Clinical characteristics and prognosis of patients with heart failure and high concentrations of interleukin-17D.
     Int J Cardiol. 2023 Sep 21:131384. doi: 10.1016/j.ijcard.2023.131384.
     PubMed     Abstract available
     
     
     
295. CHEN H, Zhen Z, Dong Y, Liu C, et al
     Hemoglobin to red cell distribution width ratio: A predictor of clinical outcome and diuretic response in patients with acute heart failure.
     Int J Cardiol. 2023 Sep 20:131368. doi: 10.1016/j.ijcard.2023.131368.
     PubMed     Abstract available
     
     
     
296. LI T, Li Z, Guo S, Jiang S, et al
     The value of using left ventricular pressure-strain loops to evaluate myocardial work in predicting heart failure with improved ejection fraction.
     Int J Cardiol. 2023 Sep 19:131366. doi: 10.1016/j.ijcard.2023.131366.
     PubMed     Abstract available
     
     
     
297. ANDI K, Abozied O, Miranda WR, Anderson JH, et al
     Clinical benefits of angiotensin receptor-Neprilysin inhibitor in adults with congenital heart disease.
     Int J Cardiol. 2023;387:131152.
     PubMed     Abstract available
     
     
     
298. TSABEDZE N, Mpanya D, Bailly C, Nel S, et al
     Clinical characteristics and one-year all-cause mortality outcomes in Africans with dilated cardiomyopathy.
     Int J Cardiol. 2023;387:131142.
     PubMed     Abstract available
     
     
     
299. LEE YH, Kim SM, Kim EK, Park SJ, et al
     Pattern of pericardial calcification determines mid-term postoperative outcomes after pericardiectomy in chronic constrictive pericarditis.
     Int J Cardiol. 2023;387:131133.
     PubMed     Abstract available
     
     
     
300. ZHANG TY, An DA, Zhou H, Ni Z, et al
     Fractal analysis: Left ventricular trabecular complexity cardiac MRI adds independent risks for heart failure with preserved ejection fraction in participants with end-stage renal disease.
     Int J Cardiol. 2023 Sep 9:131334. doi: 10.1016/j.ijcard.2023.131334.
     PubMed     Abstract available
     
     
     
301. LEE K, Jung JH, Kwon W, Ohn C, et al
     The prognostic value of cardiopulmonary exercise testing and HFA-PEFF in patients with unexplained dyspnea and preserved left ventricular ejection fraction.
     Int J Cardiol. 2023;386:74-82.
     PubMed     Abstract available
     
     
     August 2023
302. KHAZAEI S, Jenabi E
     Comment on: Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
     Int J Cardiol. 2023 Aug 22:131281. doi: 10.1016/j.ijcard.2023.131281.
     PubMed    
     
     
     
303. PUST F, Deis T, Larsson J, Hansen BL, et al
     Importance of heart failure duration for development of pulmonary hypertension in advanced heart failure.
     Int J Cardiol. 2023 Aug 19:131232. doi: 10.1016/j.ijcard.2023.131232.
     PubMed     Abstract available
     
     
     
304. CHO Y, Ueda T, Kotani S, Okada K, et al
     AATS 2023: Left ventricular restoration with scar exclusion in the surgical treatment for ischemic heart failure.
     Int J Cardiol. 2023 Aug 18:131277. doi: 10.1016/j.ijcard.2023.131277.
     PubMed     Abstract available
     
     
     
305. DOGAR ME, Azeem B, Asim R
     Comment on SGLT-2 inhibitors for treatment of heart failure in patients with and without type 2 diabetes: A practical approach for routine clinical practice.
     Int J Cardiol. 2023 Aug 9:131255. doi: 10.1016/j.ijcard.2023.131255.
     PubMed    
     
     
     
306. LO JJ, Tromp J, Ouwerkwerk W, Ong MEH, et al
     Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting.
     Int J Cardiol. 2023 Aug 1:131237. doi: 10.1016/j.ijcard.2023.131237.
     PubMed     Abstract available
     
     
     July 2023
307. SANCHIS L, Farrero M
     Edge to edge mitral valve repair beyond COAPT criteria: A bridge to further therapies for patients with advanced heart failure.
     Int J Cardiol. 2023 Jul 31:131235. doi: 10.1016/j.ijcard.2023.131235.
     PubMed    
     
     
     
308. DE CLERCQ L, Er A, Handoko ML, van Weert HCPM, et al
     Characteristics of heart failure in the Amsterdam metropolitan area (AMSTERDAM-HF): Data from a dynamic general practice cohort (2011-2021).
     Int J Cardiol. 2023 Jul 25:131217. doi: 10.1016/j.ijcard.2023.131217.
     PubMed     Abstract available
     
     
     
309. TAVERAS HIRALDO A, Canahuate Rodriguez G
     Predicting heart failure rollback.
     Int J Cardiol. 2023 Jul 20:131197. doi: 10.1016/j.ijcard.2023.131197.
     PubMed    
     
     
     
310. JONG CB, Lu TS, Chen TY, Chen CK, et al
     Subclinical myocardial injury increases the risk of heart failure in patients with and without type 2 diabetes post-acute coronary syndrome.
     Int J Cardiol. 2023 Jul 18:131195. doi: 10.1016/j.ijcard.2023.131195.
     PubMed     Abstract available
     
     
     
311. PAVLOV M, Vidak M
     Safety of benzodiazepines in patients with acute heart failure: Questions to be answered.
     Int J Cardiol. 2023 Jul 14:131191. doi: 10.1016/j.ijcard.2023.131191.
     PubMed    
     
     
     
312. ICHIHARA YK, Shiraishi Y, Kohsaka S, Nakano S, et al
     Association of pre-hospital precipitating factors with short- and long-term outcomes of acute heart failure patients: A report from the WET-HF2 registry.
     Int J Cardiol. 2023 Jul 10:131161. doi: 10.1016/j.ijcard.2023.131161.
     PubMed     Abstract available
     
     
     
313. ZITO A, Restivo A, Ciliberti G, Laborante R, et al
     Heart failure management guided by remote multiparameter monitoring: A meta-analysis.
     Int J Cardiol. 2023 Jul 8:131163. doi: 10.1016/j.ijcard.2023.131163.
     PubMed     Abstract available
     
     
     
314. SUN Y, Wang C, Ren J
     CRT upgrading might be a potential therapy in pacemaker-induced cardiomyopathy.
     Int J Cardiol. 2023;382:62.
     PubMed    
     
     
     
315. WANG RJ, Xu C, Tang HF
     A cardiovascular polypharmacy perspective on octogenarians with HFpEF.
     Int J Cardiol. 2023;382:60-61.
     PubMed    
     
     
     June 2023
316. CASTIGLIONE V, Gentile F, Vergaro G
     Cachexia, sarcopenia and heart failure: A last mile to be walked.
     Int J Cardiol. 2023 Jun 24:131131. doi: 10.1016/j.ijcard.2023.131131.
     PubMed    
     
     
     
317. MORITA K, Miyamoto Y, Mizuno A, Shirane S, et al
     Impact of a financial incentive scheme for team-based palliative care in patients with heart failure in Japan: A nationwide database study.
     Int J Cardiol. 2023 Jun 24:131145. doi: 10.1016/j.ijcard.2023.131145.
     PubMed     Abstract available
     
     
     
318. MARGONATO D, Ancona F, Cesari A, Ghantous E, et al
     The long-term clinical course of moderate tricuspid regurgitation.
     Int J Cardiol. 2023 Jun 24:131135. doi: 10.1016/j.ijcard.2023.131135.
     PubMed     Abstract available
     
     
     
319. MUNAFO AR, Scotti A, Estevez-Loureiro R, Adamo M, et al
     2-year outcomes of MitraClip as a bridge to heart transplantation: The international MitraBridge registry.
     Int J Cardiol. 2023 Jun 22:131139. doi: 10.1016/j.ijcard.2023.131139.
     PubMed     Abstract available
     
     
     
320. GALATI G, Germanova O, Pedretti RFE, Ambrosio G, et al
     Hypotension and optimization of heart failure therapy after a recent hospitalization for heart failure: When the going gets tough, the tough get going.
     Int J Cardiol. 2023 Jun 13:131118. doi: 10.1016/j.ijcard.2023.131118.
     PubMed    
     
     
     
321. CAMILLI M, Iannaccone G, Russo M, Meucci MC, et al
     Early improvement of strain imaging parameters predicts long-term response to sacubitril/valsartan in patients with heart failure with reduced ejection fraction: An observational prospective study.
     Int J Cardiol. 2023 Jun 6:S0167-5273(23)00835.
     PubMed     Abstract available
     
     
     May 2023
322. ZHANG X, Lv X, Wang N, Yu S, et al
     WATCH-DM risk score predicts the prognosis of diabetic phenotype patients with heart failure and preserved ejection fraction.
     Int J Cardiol. 2023 May 29:S0167-5273(23)00738.
     PubMed     Abstract available
     
     
     
323. MUTOLI M, Martelli F, Spinetti G
     TfR1 gene expression as a potential biomarker for iron deficiency in heart failure.
     Int J Cardiol. 2023 May 23:S0167-5273(23)00722.
     PubMed    
     
     
     
324. WU L, Wu M, Zhang X, Chen S, et al
     Increased arterial stiffness elevates the risk of heart failure in diabetic patients.
     Int J Cardiol. 2023 May 23:S0167-5273(23)00732.
     PubMed     Abstract available
     
     
     
325. ANGELICO-GONCALVES A, Leite AR, Neves JS, Saraiva F, et al
     Changes in health-related quality of life and treatment effects in chronic heart failure: A meta-analysis.
     Int J Cardiol. 2023 May 19:S0167-5273(23)00726.
     PubMed     Abstract available
     
     
     
326. MEIJS C, Brugts JJ, Lund LH, Linssen GCM, et al
     Identifying distinct clinical clusters in heart failure with mildly reduced ejection fraction.
     Int J Cardiol. 2023 May 16:S0167-5273(23)00718.
     PubMed     Abstract available
     
     
     
327. CABRERA C, Frisk C, Lofstrom U, Lynga P, et al
     Relationship between iron deficiency and expression of genes involved in iron metabolism in human myocardium and skeletal muscle.
     Int J Cardiol. 2023;379:82-88.
     PubMed     Abstract available
     
     
     
328. KUCHTARUK AA, Sparrow RT, Azzalini L, Garcia S, et al
     Unplanned readmissions after Impella mechanical circulatory support.
     Int J Cardiol. 2023;379:48-59.
     PubMed     Abstract available
     
     
     
329. ALHAKAK AS, Olsen FJ, Skaarup KG, Lassen MCH, et al
     Changes in cardiac time intervals over a decade and the risk of incident heart failure: The Copenhagen City heart study.
     Int J Cardiol. 2023 May 11:S0167-5273(23)00709.
     PubMed     Abstract available
     
     
     
330. MELENDO-VIU M, Dobarro D, Lopez AM, Dominguez LM, et al
     Hypotension at heart failure discharge: Should it be a limiting factor for drug titration?
     Int J Cardiol. 2023 May 9:S0167-5273(23)00658.
     PubMed     Abstract available
     
     
     
331. MAGRI D, Palermo P, Salvioni E, Mapelli M, et al
     Influence of exertional oscillatory breathing and its temporal behavior in patients with heart failure and reduced ejection fraction.
     Int J Cardiol. 2023 May 8:S0167-5273(23)00659.
     PubMed     Abstract available
     
     
     
332. FRANCESCO A, Davide M, Gregorio M, Matteo B, et al
     Ratio between right ventricular longitudinal strain and pulmonary arterial systolic pressure: A novel prognostic parameter in patients with severe tricuspid regurgitation.
     Int J Cardiol. 2023 May 4:S0167-5273(23)00647.
     PubMed     Abstract available
     
     
     
333. KOH SJQ, Yap J, Jiang Y, Sng GGR, et al
     Clinical outcomes in end stage renal disease on dialysis and severe coronary artery disease: A real-world study.
     Int J Cardiol. 2023;378:105-110.
     PubMed     Abstract available
     
     
     April 2023
334. ASAUMI Y
     Peripheral vein pressure as a less-invasive marker at the vulnerable phase after hospitalization of heart failure.
     Int J Cardiol. 2023 Apr 28:S0167-5273(23)00593.
     PubMed    
     
     
     
335. BOTTIROLI M, Calini A, Morici N, Tavazzi G, et al
     Acute kidney injury in patients with acute decompensated heart failure-cardiogenic shock: Prevalence, risk factors and outcome.
     Int J Cardiol. 2023 Apr 28:S0167-5273(23)00612.
     PubMed     Abstract available
     
     
     
336. ZEITOUNI M, Morlon Q, Silvain J, Procopi N, et al
     Implication of the new definition of pulmonary hypertension in patients evaluated for heart transplantation.
     Int J Cardiol. 2023 Apr 27:S0167-5273(23)00602.
     PubMed     Abstract available
     
     
     
337. SINGAM NSV, Tabi M, Wiley B, Anavekar N, et al
     Echocardiographic findings in cardiogenic shock due to acute myocardial infarction versus heart failure.
     Int J Cardiol. 2023 Apr 26:S0167-5273(23)00595.
     PubMed     Abstract available
     
     
     
338. NISHINO M, Egami Y, Yamada T, Yasumura Y, et al
     Reply to "Prognostic impact of cardiovascular polypharmacy on octogenarians with heart failure with preserved ejection fraction".
     Int J Cardiol. 2023 Apr 17:S0167-5273(23)00536.
     PubMed    
     
     
     
339. FERREIRA JP, Cleland JG, Girerd N, Rossignol P, et al
     Spironolactone effect on circulating procollagen type I carboxy-terminal propeptide: Pooled analysis of three randomized trials.
     Int J Cardiol. 2023;377:86-88.
     PubMed     Abstract available
     
     
     
340. CHRISTOPH M, Marius S, Karl S, Friedrich K, et al
     Efficacy of CRT upgrade in pacemaker-induced cardiomyopathy in an outpatient clinic - Results of a prospective registry.
     Int J Cardiol. 2023;377:60-65.
     PubMed     Abstract available
     
     
     
341. YANG Q, Wu H, Liu D, Li Y, et al
     Discussion of a study on the role of EMS in prognosis of elderly patients with AHF.
     Int J Cardiol. 2023;377:91.
     PubMed    
     
     
     
342. SALAMANCA-BAUTISTA P, Romero-Correa M, Formiga F, Antequera-Martin-Portugues I, et al
     Safety of benzodiazepines in patients with acute heart failure: A propensity score-matching study.
     Int J Cardiol. 2023 Apr 14:S0167-5273(23)00529.
     PubMed     Abstract available
     
     
     
343. EDER M, Griffin M, Moreno-Villagomez J, Bellumkonda L, et al
     The importance of forward flow and venous congestion in diuretic response in acute heart failure: Insights from the ESCAPE trial.
     Int J Cardiol. 2023 Apr 4:S0167-5273(23)00517.
     PubMed     Abstract available
     
     
     March 2023
344. LUO Q, Zhuang B, Li G, Jiang Y, et al
     Consistency evaluation of exercise target heart rate determined by resting heart rate and anaerobic threshold in chronic heart failure patients.
     Int J Cardiol. 2023 Mar 29:S0167-5273(23)00467.
     PubMed     Abstract available
     
     
     
345. HORTEGAL RA, Valeri R, Grizante M, Cancellier R, et al
     Afterload increase challenge unmasks systolic abnormalities in heart failure with preserved ejection fraction.
     Int J Cardiol. 2023 Mar 21:S0167-5273(23)00453.
     PubMed     Abstract available
     
     
     
346. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
     Prevalence and prognostic impact of the coexistence of cachexia and sarcopenia in older patients with heart failure.
     Int J Cardiol. 2023 Mar 17:S0167-5273(23)00447.
     PubMed     Abstract available
     
     
     
347. TAKIMURA H, Taniguchi R, Tsuzuki I, Tajima E, et al
     Impact of the time-to-target rate of urine volume concept on the outcome of acute decompensated heart failure.
     Int J Cardiol. 2023 Mar 17:S0167-5273(23)00445.
     PubMed     Abstract available
     
     
     
348. KUMAR HU, Nearing BD, Mittal S, Premchand RK, et al
     Autonomic regulation therapy in chronic heart failure with preserved/mildly reduced ejection fraction: ANTHEM-HFpEF study results.
     Int J Cardiol. 2023 Mar 17:S0167-5273(23)00440.
     PubMed     Abstract available
     
     
     
349. FUJIMOTO Y, Maeda D, Kagiyama N, Sunayama T, et al
     Prognostic implications of six-minute walking distance in patients with heart failure with preserved ejection fraction.
     Int J Cardiol. 2023 Mar 11:S0167-5273(23)00396.
     PubMed     Abstract available
     
     
     
350. BURGER PM, Koudstaal S, Dorresteijn JAN, Savarese G, et al
     Metabolic syndrome and risk of incident heart failure in non-diabetic patients with established cardiovascular disease.
     Int J Cardiol. 2023 Mar 11:S0167-5273(23)00395.
     PubMed     Abstract available
     
     
     
351. HEEGAARD B, Deis T, Rossing K, Ersboll M, et al
     Diabetes mellitus and hemodynamics in advanced heart failure.
     Int J Cardiol. 2023 Mar 10:S0167-5273(23)00341.
     PubMed     Abstract available
     
     
     
352. KAWAJI T, Shiomi H, Bao B, Hojo S, et al
     Intracardiac energy inefficiency during atrial fibrillation rhythm with heart failure: Assessment by echo-vector flow mapping.
     Int J Cardiol. 2023 Mar 10:S0167-5273(23)00392.
     PubMed     Abstract available
     
     
     
353. DURAN A, Ventura HO
     The value of frequent objective risk assessments in heart failure management.
     Int J Cardiol. 2023 Mar 6:S0167-5273(23)00333.
     PubMed    
     
     
     
354. MOHEBI R, Liu Y, Murphy SP, Gaggin HK, et al
     Clinical profiling of end-stage heart failure with preserved ejection fraction: The National Readmission Database.
     Int J Cardiol. 2023 Mar 2:S0167-5273(23)00269.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.